| Amy M Arisco, MD | |
|
1311 E. Division Street, Mount Vernon, WA 98274 | |
| (360) 424-7991 | |
| (360) 428-4377 |
| Full Name | Amy M Arisco |
|---|---|
| Gender | Female |
| Speciality | Urology |
| Experience | 24 Years |
| Location | 1311 E. Division Street, Mount Vernon, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821183856 | NPI | - | NPPES |
| 183936701 | Medicaid | TX |
| Facility Name | Location | Facility Type |
|---|---|---|
| Westfields Hospital And Clinic | New richmond, WI | Hospital |
| Amery Hospital & Clinic | Amery, WI | Hospital |
| Lakeview Memorial Hospital | Stillwater, MN | Hospital |
| Providence St Peter Hospital | Olympia, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Washington | 6709782600 | 393 |
| Healthpartners Medical Group | 1759293954 | 1430 |
| Amery Regional Medical Center Inc | 2769391960 | 97 |
News Archive
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.
An international group of almost 1000 medical experts gathers this week to discuss the most current treatments for children with heart disease. Affecting about a million children born each year throughout the world, congenital heart disease is the most common birth defect. In its severe forms, it is also the leading cause of death from birth defects in infants.
In a recent report posted to the bioRxiv preprint server, researchers from the United Kingdom and Uganda reveal unique protein features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) relative to other representatives of Sarbecoviruses.
Cellectar, Inc. has announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for its (131)I-CLR1404 drug candidate for testing in patients with advanced solid malignancies.
› Verified 3 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174744304 PECOS PAC ID: 6709782600 Enrollment ID: O20031211000028 |
News Archive
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.
An international group of almost 1000 medical experts gathers this week to discuss the most current treatments for children with heart disease. Affecting about a million children born each year throughout the world, congenital heart disease is the most common birth defect. In its severe forms, it is also the leading cause of death from birth defects in infants.
In a recent report posted to the bioRxiv preprint server, researchers from the United Kingdom and Uganda reveal unique protein features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) relative to other representatives of Sarbecoviruses.
Cellectar, Inc. has announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for its (131)I-CLR1404 drug candidate for testing in patients with advanced solid malignancies.
› Verified 3 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619176997 PECOS PAC ID: 7719873496 Enrollment ID: O20040227000744 |
News Archive
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.
An international group of almost 1000 medical experts gathers this week to discuss the most current treatments for children with heart disease. Affecting about a million children born each year throughout the world, congenital heart disease is the most common birth defect. In its severe forms, it is also the leading cause of death from birth defects in infants.
In a recent report posted to the bioRxiv preprint server, researchers from the United Kingdom and Uganda reveal unique protein features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) relative to other representatives of Sarbecoviruses.
Cellectar, Inc. has announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for its (131)I-CLR1404 drug candidate for testing in patients with advanced solid malignancies.
› Verified 3 days ago
| Entity Name | Public Hospital Dist No 1 Skagit |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023332749 PECOS PAC ID: 6800793522 Enrollment ID: O20040309001059 |
News Archive
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.
An international group of almost 1000 medical experts gathers this week to discuss the most current treatments for children with heart disease. Affecting about a million children born each year throughout the world, congenital heart disease is the most common birth defect. In its severe forms, it is also the leading cause of death from birth defects in infants.
In a recent report posted to the bioRxiv preprint server, researchers from the United Kingdom and Uganda reveal unique protein features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) relative to other representatives of Sarbecoviruses.
Cellectar, Inc. has announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for its (131)I-CLR1404 drug candidate for testing in patients with advanced solid malignancies.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy M Arisco, MD 1400 E. Kincaid Street, Attn: Credentialing, Mount Vernon, WA 98274 Ph: (360) 428-2500 | Amy M Arisco, MD 1311 E. Division Street, Mount Vernon, WA 98274 Ph: (360) 424-7991 |
News Archive
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.
An international group of almost 1000 medical experts gathers this week to discuss the most current treatments for children with heart disease. Affecting about a million children born each year throughout the world, congenital heart disease is the most common birth defect. In its severe forms, it is also the leading cause of death from birth defects in infants.
In a recent report posted to the bioRxiv preprint server, researchers from the United Kingdom and Uganda reveal unique protein features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) relative to other representatives of Sarbecoviruses.
Cellectar, Inc. has announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for its (131)I-CLR1404 drug candidate for testing in patients with advanced solid malignancies.
› Verified 3 days ago
Jordan James Kramer, MD Urology Medicare: Medicare Enrolled Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-814-6565 Fax: 360-814-6380 | |
Dr. Laurence M. Lee, MD Urology Medicare: Medicare Enrolled Practice Location: 1311 E. Division Street, Mount Vernon, WA 98274 Phone: 360-424-7991 Fax: 360-428-4377 | |
Dr. Martin R. Curlik, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-814-6565 | |
Dr. Winston G. Jones, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1311 E. Division Street, Mount Vernon, WA 98274 Phone: 360-424-7991 Fax: 360-428-4377 | |
Dr. Richard Von Ho, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-814-6565 Fax: 360-814-6380 | |
Dr. Curran James Emeruwa, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-814-6565 | |
Dr. Darrell R. Cornelius, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1311 E. Division Street, Mount Vernon, WA 98274 Phone: 360-424-7991 Fax: 360-428-4377 |